Ironwood Pharma (IRWD) Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease

Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Ironwood+Pharma+%28IRWD%29+Announces+Positive+Results+from+its+Phase+II+Exploratory+STARGAZE+Trial+of+Apraglutide+in+Patients+with+Steroid-Refractory+Gastrointestinal+Acute+Graft-versus-Host+Disease/22991214.html for the full story.